Christopher & Banks (CBK) Tops Q1 EPS by 10c; Q2 Revenue Outlook Light of Views

Christopher & Banks (NYSE: CBK) reported Q1 EPS of $0.00, $0.10 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $100 million versus the consensus estimate of $96.88 million.

Comparable sales increased 6.0% compared to an 11.7% decrease in the same period last year.

GUIDANCE:

Christopher & Banks sees Q2 2016 revenue of $92-96 million, versus the consensus of $97.4 million.

For earnings history and earnings-related data on Christopher & Banks (CBK) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• PTC Therapeutics (PTCT) Tops Q1 EPS by 9c, provides guidance
• Juniper Networks (JNPR) Misses Q1 EPS by 12c